146 related articles for article (PubMed ID: 38740628)
1. History of Rectal Product Use and Country of Residence Influence Preference for Rectal Microbicide Dosage Forms Among Young Sexual and Gender Minorities: A Multi-country Trial Comparing Placebo Douche, Suppository, and Insert Products.
Giguere R; Balán IC; Kutner BA; Choi SK; Tingler R; Johnson S; Macagna N; Webster J; Liu A; Chariyalertsak S; Hoesley C; Gonzales P; Ho K; Kayange N; Palanee-Phillips T; Brown E; Zemanek J; Jacobson CE; Doncel GF; Piper J; Bauermeister JA;
AIDS Behav; 2024 May; ():. PubMed ID: 38740628
[TBL] [Abstract][Full Text] [Related]
2. A latent trajectory analysis of young sexual and gender minorities' adherence to three rectal microbicide placebo formulations (MTN-035; a randomized crossover trial).
Choi SK; Bauermeister J; Tingler RC; Johnson S; Macagna N; Ho K; Hoesley C; Liu A; Kayange N; Palanee-Phillips T; Chariyalertsak S; Gonzales P; Piper JM;
BMC Public Health; 2023 Dec; 23(1):2464. PubMed ID: 38066471
[TBL] [Abstract][Full Text] [Related]
3. A randomized trial of safety, acceptability and adherence of three rectal microbicide placebo formulations among young sexual and gender minorities who engage in receptive anal intercourse (MTN-035).
Bauermeister JA; Dominguez Islas C; Jiao Y; Tingler R; Brown E; Zemanek J; Giguere R; Balan I; Johnson S; Macagna N; Lucas J; Rose M; Jacobson C; Collins C; Livant E; Singh D; Ho K; Hoesley C; Liu A; Kayange N; Palanee-Phillips T; Chariyalertsak S; Gonzales P; Piper J;
PLoS One; 2023; 18(4):e0284339. PubMed ID: 37043527
[TBL] [Abstract][Full Text] [Related]
4. A conjoint experiment of three placebo rectal products used with receptive anal sex: results from MTN-035.
Bauermeister J; Lin W; Tingler R; Liu A; Chariyalertsak S; Hoesley C; Gonzales P; Ho K; Kayange N; Phillips TP; Johnson S; Brown E; Zemanek J; Jacobson CE; Doncel GF; Piper J;
J Int AIDS Soc; 2024 Mar; 27(3):e26219. PubMed ID: 38494656
[TBL] [Abstract][Full Text] [Related]
5. Preference for gel over suppository as delivery vehicle for a rectal microbicide: results of a randomised, crossover acceptability trial among men who have sex with men.
Carballo-Diéguez A; Dolezal C; Bauermeister JA; O'Brien W; Ventuneac A; Mayer K
Sex Transm Infect; 2008 Nov; 84(6):483-7. PubMed ID: 19028952
[TBL] [Abstract][Full Text] [Related]
6. Rectal Douching and Microbicide Acceptability among Young Men who Have Sex with Men.
Tingler RC; Connochie D; Bauermeister JA
AIDS Behav; 2020 May; 24(5):1414-1421. PubMed ID: 31473846
[TBL] [Abstract][Full Text] [Related]
7. Rectal Douching Prevalence and Practices Among Peruvian Men Who have Sex with Men and Transwomen: Implications for Rectal Microbicides.
Galea JT; Kinsler JJ; McLean S; Calvo G; Sánchez H; Leon SR; Brown B
AIDS Behav; 2016 Nov; 20(11):2555-2564. PubMed ID: 26459331
[TBL] [Abstract][Full Text] [Related]
8. Rectal douching and implications for rectal microbicides among populations vulnerable to HIV in South America: a qualitative study.
Galea JT; Kinsler JJ; Imrie J; Nureña CR; Sánchez J; Cunningham WE
Sex Transm Infect; 2014 Feb; 90(1):33-5. PubMed ID: 23966338
[TBL] [Abstract][Full Text] [Related]
9. Stated product formulation preferences for HIV pre-exposure prophylaxis among women in the VOICE-D (MTN-003D) study.
Luecke EH; Cheng H; Woeber K; Nakyanzi T; Mudekunye-Mahaka IC; van der Straten A;
J Int AIDS Soc; 2016; 19(1):20875. PubMed ID: 27247202
[TBL] [Abstract][Full Text] [Related]
10. End-user preference for and choice of four vaginally delivered HIV prevention methods among young women in South Africa and Zimbabwe: the Quatro Clinical Crossover Study.
Montgomery ET; Beksinska M; Mgodi N; Schwartz J; Weinrib R; Browne EN; Mphili N; Musara P; Jaggernath M; Ju S; Smit J; Chirenje ZM; Doncel GF; van der Straten A
J Int AIDS Soc; 2019 May; 22(5):e25283. PubMed ID: 31069957
[TBL] [Abstract][Full Text] [Related]
11. High levels of adherence to a rectal microbicide gel and to oral Pre-Exposure Prophylaxis (PrEP) achieved in MTN-017 among men who have sex with men (MSM) and transgender women.
Carballo-Diéguez A; Balán IC; Brown W; Giguere R; Dolezal C; Leu CS; Marzinke MA; Hendrix CW; Piper JM; Richardson BA; Grossman C; Johnson S; Gomez K; Horn S; Kunjara Na Ayudhya RP; Patterson K; Jacobson C; Bekker LG; Chariyalertsak S; Chitwarakorn A; Gonzales P; Holtz TH; Liu A; Mayer KH; Zorrilla C; Lama J; McGowan I; Cranston RD
PLoS One; 2017; 12(7):e0181607. PubMed ID: 28750059
[TBL] [Abstract][Full Text] [Related]
12. Who prefers what? Correlates of preferences for next-generation HIV prevention products among a national U.S. sample of young men who have sex with men.
Biello KB; Valente PK; da Silva DT; Lin W; Drab R; Hightow-Weidman L; Mayer KH; Bauermeister JA;
J Int AIDS Soc; 2023 Jul; 26 Suppl 2(Suppl 2):e26096. PubMed ID: 37439061
[TBL] [Abstract][Full Text] [Related]
13. Acceptability of vaginal film, soft-gel capsule, and tablet as potential microbicide delivery methods among African women.
Nel AM; Mitchnick LB; Risha P; Muungo LT; Norick PM
J Womens Health (Larchmt); 2011 Aug; 20(8):1207-14. PubMed ID: 21774672
[TBL] [Abstract][Full Text] [Related]
14. Preference for using a variety of future HIV pre-exposure prophylaxis products among men who have sex with men in three US cities.
Mansergh G; Kota KK; Stephenson R; Hirshfield S; Sullivan P
J Int AIDS Soc; 2021 Jan; 24(1):e25664. PubMed ID: 33481359
[TBL] [Abstract][Full Text] [Related]
15. Anal Douche Practices and Willingness to Use a Rectal Microbicide Enema for HIV Prevention and Associated Factors Among an Internet Sample of HIV-Negative and HIV-Discordant Male Couples in the US.
Mitchell JW; Sophus AI; Lee JY; Petroll AE
AIDS Behav; 2016 Nov; 20(11):2578-2587. PubMed ID: 26597502
[TBL] [Abstract][Full Text] [Related]
16. Lessons for Rectal Microbicide Development From an Acceptability Trial of a Placebo Gel Applied Prior to Receptive Anal Intercourse.
Frasca T; Giguere R; Ibitoye M; Dolezal C; Febo I; Cranston RD; Mayer K; McGowan I; Carballo-Diéguez A
Arch Sex Behav; 2017 May; 46(4):1101-1109. PubMed ID: 27129533
[TBL] [Abstract][Full Text] [Related]
17. Are participants concerned about privacy and security when using short message service to report product adherence in a rectal microbicide trial?
Giguere R; Brown W; Balán IC; Dolezal C; Ho T; Sheinfil A; Ibitoye M; Lama JR; McGowan I; Cranston RD; Carballo-Diéguez A
J Am Med Inform Assoc; 2018 Apr; 25(4):393-400. PubMed ID: 29025127
[TBL] [Abstract][Full Text] [Related]
18. Using conjoint analysis to determine the impact of product and user characteristics on acceptability of rectal microbicides for HIV prevention among Peruvian men who have sex with men.
Tang EC; Galea JT; Kinsler JJ; Gonzales P; Sobieszczyk ME; Sanchez J; Lama JR
Sex Transm Infect; 2016 May; 92(3):200-5. PubMed ID: 26574569
[TBL] [Abstract][Full Text] [Related]
19. Rectal Douching Among Men Who Have Sex with Men in Paris: Implications for HIV/STI Risk Behaviors and Rectal Microbicide Development.
Hambrick HR; Park SH; Goedel WC; Morganstein JG; Kreski NT; Mgbako O; Duncan DT
AIDS Behav; 2018 Feb; 22(2):379-387. PubMed ID: 28766026
[TBL] [Abstract][Full Text] [Related]
20. Preferences and Acceptability of Vaginal Delivery Forms for HIV Prevention Among Women, Male Partners and Key Informants in South Africa and Zimbabwe: Qualitative Findings.
Musara P; Milford C; Shapley-Quinn MK; Weinrib R; Mutero P; Odoom E; Mgodi NM; Chirenje ZM; Hanif H; Clark MR; Smit J; van der Straten A; Montgomery ET;
AIDS Behav; 2021 Jan; 25(1):124-138. PubMed ID: 32588257
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
